Pacific Diabetes Technologies
Portland, US · Founded 2021 · Delaware corporation
Pacific DT develops a patented prototype system emerging from university research with support from major health foundations and government agencies. The company is transitioning from research stage toward commercial clinical applications.
Founders & leadership
Pacific Diabetes Technologies was founded in 2021 by W. Kenneth Ward.
WK
W. Kenneth WardinCo-Founder
TS
Thomas SeidelExecutive
Board
EL
Edward La CavaBoard director
KW
Ken WardBoard director
PE
Peter EckenbergCEO, Director
YB
Yobie BenjaminBoard director
Reported raises · per SEC filings
Form D private placements$7M disclosed across 3 of 4 rounds · 2021–2025
▶$3.4MraisedNov 2025 · 15 investors · BiotechnologyRule 506(b)
▶$3.4MraisedNov 2025 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas SeidlExecutive Officer, Director, Promoter
- Hank WuhDirector
- Christopher MarshDirector
- Offering amount
- $3.5M
- Amount sold
- $3.4M
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$2.1MraisedMar 2025 · 5 investors · BiotechnologyRule 506(b)
▶$2.1MraisedMar 2025 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Hank WuhDirector
- Mark HuberDirector
- Peter EckenbergDirector
- Christopher MarshDirector
- Kenneth WardDirector
- Thomas SeidlExecutive Officer, Director
- Ed La CavaDirector
- Offering amount
- $5M
- Amount sold
- $2.1M
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$1.5MraisedSep 2024 · 17 investors · BiotechnologyRule 506(b)
▶$1.5MraisedSep 2024 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Edward La CavaDirector
- Ken WardDirector
- Thomas SeidelExecutive Officer, Director
- Peter EckenbergDirector
- Yobie BenjaminDirector
- Offering amount
- $5M
- Amount sold
- $1.5M
- Minimum investment
- $250K
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$2MofferedJun 2021 · BiotechnologyRule 506(b)
▶$2MofferedJun 2021 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas SeidelExecutive Officer
- Offering amount
- $2M
- Minimum investment
- $25K
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Diabetes3 shared keywordsA nonprofit organization that provides educational resources and information about prediabetes, including prevention strategies and lifestyle management for Americans at risk of developing type 2 diabetes.
Tandem Diabetes Care, Inc.3 shared keywordsTandem Diabetes manufactures infusion sets—tubing systems with subcutaneous delivery sites—designed for use with insulin pumps to manage diabetes. The product line includes several models (AutoSoft XC, AutoSoft 30, VariSoft, TruSteel) with varying insertion angles and tubing lengths.
Companies competing with Pacific Diabetes Technologies for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Pacific Diabetes Technologies do?
- Pacific DT develops a patented prototype system emerging from university research with support from major health foundations and government agencies. The company is transitioning from research stage toward commercial clinical applications.
- Who founded Pacific Diabetes Technologies?
- Pacific Diabetes Technologies was founded by W. Kenneth Ward in 2021.
- How much funding has Pacific Diabetes Technologies raised?
- Pacific Diabetes Technologies has disclosed $7M raised across 3 of its 4 known rounds.
- Where is Pacific Diabetes Technologies headquartered?
- Pacific Diabetes Technologies is headquartered in Portland, US.